Timothy Kelly
Chief Tech/Sci/R&D Officer bei CARIBOU BIOSCIENCES, INC.
Profil
Timothy P.
Kelly is currently the Chief Executive Officer at Oxford Biomedica Solutions LLC and the Chief Technology Officer at Caribou Biosciences, Inc. He previously served as the Chairman & Chief Executive Officer at Oxford Biomedica Solutions LLC.
He also held positions at Biogen, Inc. as Senior Director-International Operations from 1998 to 2005, at Sarepta Therapeutics, Inc. as Head-Technical Operations in 2017, at Shire Plc as Senior Vice President & Head-Biologics Operating from 2009 to 2017, at UCB SA as Head-Technical Operations from 2005 to 2009, and at Homology Medicines, Inc. as Chief Operating Officer from 2017 to 2022.
Mr. Kelly received his undergraduate degree from the United States Air Force Academy and an MBA from Troy University.
Aktive Positionen von Timothy Kelly
| Unternehmen | Position | Beginn |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 07.01.2024 |
Oxford Biomedica Solutions LLC
 Oxford Biomedica Solutions LLC Industrial MachineryProducer Manufacturing Oxford Biomedica Solutions LLC is a development partner that offers a plug and play platform for partners to achieve high titer and high product quality vector. The platform has already been proven with six separate new product inds and ctas. The American company's approach to AAV manufacturing is through continuous innovation to ensure they are delivering the highest product quality and efficacy to patients. The CEO of the joint venture company is Timothy P. Kelly. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Timothy Kelly
| Unternehmen | Position | Ende |
|---|---|---|
| Q32 BIO INC. | Chief Operating Officer | 10.03.2022 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.05.2017 |
| SHIRE | Corporate Officer/Principal | 01.01.2017 |
| UCB | Corporate Officer/Principal | 01.01.2009 |
| BIOGEN INC. | Corporate Officer/Principal | 01.01.2005 |
Ausbildung von Timothy Kelly
| United States Air Force Academy | Undergraduate Degree |
| Troy University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| BIOGEN INC. | Health Technology |
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| CARIBOU BIOSCIENCES, INC. | Health Technology |
| UCB | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
Oxford Biomedica Solutions LLC
Oxford Biomedica Solutions LLC Industrial MachineryProducer Manufacturing Oxford Biomedica Solutions LLC is a development partner that offers a plug and play platform for partners to achieve high titer and high product quality vector. The platform has already been proven with six separate new product inds and ctas. The American company's approach to AAV manufacturing is through continuous innovation to ensure they are delivering the highest product quality and efficacy to patients. The CEO of the joint venture company is Timothy P. Kelly. | Producer Manufacturing |
